Connection

Peter Jüni to Purinergic P2Y Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Peter Jüni has written about Purinergic P2Y Receptor Antagonists.
Peter Jüni
Connection Strength
0.331
Purinergic P2Y Receptor Antagonists
  1. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial. Eur Heart J. 2019 08 14; 40(31):2595-2604.
    View in: PubMed
    Score: 0.171
  2. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018 09 15; 392(10151):940-949.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.